| ID | Sequence | Length | GC content |
|---|---|---|---|
| AAACCGGGAUGUUGCGGGCCGUAGCGCGUGGGCGGCCGUGGGGUCUUGG… | 1602 nt | 0.4282 | |
| AAGGCCUGCCGGUUGCUCGGGGUCGUAUGACGCACUUUUCCAGCUCGAG… | 1392 nt | 0.4102 | |
| AAGGCCUGCCGGUUGCUCGGGGUCGUAUGACGCACUUUUCCAGCUCGAG… | 1520 nt | 0.4013 | |
| AAGGCCUGCCGGUUGCUCGGGGUCGUAUGACGCACUUUUCCAGCUCGAG… | 1508 nt | 0.4191 | |
| AAGGCCUGCCGGUUGCUCGGGGUCGUAUGACGCACUUUUCCAGCUCGAG… | 1266 nt | 0.3894 |
The process of transferring lipoic acid to proteins is a two-step process. The first step is the activation of lipoic acid by lipoate-activating enzyme to form lipoyl-AMP. For the second step, the protein encoded by this gene transfers the lipoyl moiety to apoproteins. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 13. Read-through transcription also exists between this gene and the neighboring downstream mitochondrial ribosomal protein L30 (MRPL30) gene. [provided by RefSeq, Mar 2011]
A study in humans identified the LIPT1 as a key differentially expressed cuproptosis-related gene (DECuG) in sepsis, where it was significantly dysregulated in validation cohorts and showed a major distribution in monocytes, T cells, B cells, and NK cells at the single-cell RNA level [Wang et al. DOI:10.1016/j.heliyon.2024.e27379].